As described, the PRINS method is a very rapid and reliable way of staining human telomeres. To obtain the maximum frequency of stained telomeres, the primer (CCCTAA)7 should be used, although the average frequency never quite reaches 100 %. The frequency is strongly dependent on the age of the individual, being significantly higher in children and newborns than in adults. A difference between the (CCCTAA)7 primer and the complementary primer is demonstrated and a possible explanation is proposed, namely, that gaps in the C-rich strand cause chain elongation termination after the addition of only one dTTP molecule.
Objective To estimate the fetal loss of Down's syndrome fetuses between the time of chorionic villus sampling (10 weeks gestation) and the time of amniocentesis (16 weeks gestation) and term in women aged 35 years and older. Design The age specific prevalence rates in the first trimester of Down's syndrome were estimated using the Danish cytogenetic register in combination with results from four published studies. These were compared with the reported prevalence at the time of amniocentesis and at birth. Subjects 5927 singleton pregnancies undergoing chorionic villus sampling (71 cases of Down's syndrome and 5856 unaffected cases). This was combined with published data on a further 231 cases of Down's syndrome and 16620 unaffected cases. Main outcome measures Age specific prevalences at the time of chorionic villus sampling. Proportion of pregnancies lost between the time of chorionic villus sampling and the time of amniocentesis and term. Results Thirty‐two percent of Down's syndrome pregnancies are lost between the time of chorionic villus sampling (10 weeks) and the time of amniocentesis (16 weeks) and 54% are lost by term. Conclusions The high fetal loss rates of Down's syndrome between the time of chorionic villus sampling and term introduce problems when evaluating first trimester screening tests with respect to their effective detection rates at term. A recommendation for quoting term risks is made.
A major problem in cultivating normal human skin epithelium is overgrowth of the epidermal cells by fibroblasts. In this report we show that it is possible to obtain pure epithelial cell cultures by lowering the incubation temperature to 32-33 degrees C. Whereas the epithelial growth proceeds unchanged at this temperature, the growth of fibroblasts is strongly inhibited.
be evidence that many of the fetuses have been chronically exposed to high levels of carbon monoxide3.It would have been instructive to know the maternal COHb levelsor better yet, plasma cotinine levels. In any case, if one accepts our contention that if the COHb levels in fetuses of nonsmoking mothers are indeed close to 1%, then the COHb levels due to smoking are not double, but at least six times higher than that of the nonsmokers. The full impact of smoking during pregnancy on the fetus remains uncertain but may be an important factor affecting neonatal outcome. AUTHORS' REPLY Sir,We are very grateful to Dr Vreman et aL's interest in the higher than expected control values of fetal COHb reported in our paper. In response to their points:1 . We note their confirmation of the good performance of our equipment at the high levels of COHb found in the blood of fetuses whose mothers smoke. 2. We do not believe our samples could have been contaminated at collection. 3. The correction for HbF assumed 90% of the blood was fetal haemoglobin and so should have been adequate. 4 . The study was undertaken in central London in an area with heavy traffic and high pollution levels. 5. We were concerned that smoking may have been under reported (which is why the quantity smoked was not included in the paper) but the patients knew the information as to whether they smoked or not was important for our research, and we believe this information to be accurate.We would like to add two more suggestions for the relatively high control levels. First, the data quoted in Vreman et al. 's letter suggests that newborn babies have lower COHb levels than fetuses and it is entirely possible that there are changes with gestational age, perhaps associated with the normal change in the proportion of HbF. Second, we did not allow for the effects of passive smoking. We agree with Vreman et al. that any elevation in the control data resulting from these potential problems would only have reduced the apparent statistical and clinical importance of our findings in smokers. The differences may therefore be even more significant than they appeared in the paper. The selective miscarriage of Down's syndrome from 10 weeks of pregnancy Sir, We would like to draw your readers' attention to an error in our paper (Vol 102, October 1995)', which was kindly brought to our attention by Jane Halliday and Lyn Watson of the Murdoch Institute in Melbourne. Table 1 shows the published estimates of the prevalence of Down's syndrome pregnancy at the time of chorion villus sampling (CVS), amniocentesis, and term (live births), together with our corrected figures. The reason for the correction is that the estimates of the prevalences of Down's syndrome at amniocentesis and at term were derived using maternal age at the time of CVS instead of at term, which we should have done to make the estimates comparable with the birth estimates at term. The revised figures indicate that between about 10 weeks of pregnancy and term an estimated 48% of Down's syndrome pregnancies ...
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.